Medical significance of cysteine protease inhibitors in mammalian secretory fluids by Katunuma, Nobuhiko et al.
INTRODUCTION
[I] Physiological roles of cysteine proteases.
Cysteine proteases, cathepsins, play an essential
role inmaintaining life in all living organisms. Cysteine
proteases are synthesized in bound ribosomes and
secreted from the trans-golgi, and then translocated
into two ways, one is targeted into lysosomes and the
other is secreted to the outside of cells through the
secretion vesicles. Cathepsins located in lysosomes
mainly play a role in protein catabolism via autophagy
and heterophagy. On the other hand, the secreted
cathepsins play a role in the processing of various
biological active proteins, such as the processing of
cytokines, hormones and inflammatory peptides. About
10 kinds of cathepsins have been reported and they
have different functions and different catalytic properties.
They play roles not only in protein catabolism, but also
in the production of biologically active peptides by
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their limited proteolysis, such as antigen processing
to present toMHCclassⅡ(1 - 4), andalsointheprocessing
of various precursor proproteins (5). The hyper-function
or low function of certain cathepsins results in specific
metabolic error diseases. Therefore, intracellular regula-
tion of cathepsin activities by their endogenous inhibitors
in situ is very important.
[II] Physiological functions of endogenous cysteine
protease inhibitors.
Cystatinα (A) in the skin and cystatin β (B) in the liver
have been discovered byKatunuma’s group and Turk’s
group, as the first endogenous proteinous inhibitors
of cathepsins in mammals (6, 22). The cystatin family
is classified into two groups, one group having low
molecular weight withmolecularweightsof 10 -20 kDa,
the others being highmolecular weight inhibitorshaving
a repeated peptide domain, such as kinin in the serum.
Various kinds of cystatins are located in various organs
and secretory fluids and they have three common bind-
ing domainswith cathepsins in theirmolecules. Intracel-
lular cystatins are principally located in the cytoplasm
and various cystatins are also secreted into physiological
secretory fluids such as tears, saliva or serum. However,
the mechanism of action of cystatins in regulating the
intralysosomal cathepsins has been relatively unclear.
On the other hand, it was reported that the cystatins
show strong bactericidal and virucidal functions due
to the inhibition of cathepsins in bacteria. Katunuma
et al reported that phosphorylated cystatin α located
in the skin epidermis shows strong bactericidal action
to Staphylococcus aureus V8 (7) and also Korant et al.
reported that proliferation of poliovirus is strongly
inhibited (8). Because, cysteine proteases in bacteria
and viruses play important roles in maintaining their
metabolism and life. Therefore, cysteineprotease inhibitor
play important roles in anti-septic and anti-infectious
functions.
Recently, a different type of cathepsin inhibitor from
the typical cystatin family was reported, by Hof et al.,
that is, Von Ebner’s Gland (VEG) protein in human
tears(9). The VEG protein inhibits cathepsins con-
siderably, however the VEG protein contains only one
homologous active domain sequence with a common
active site with the cystatin family, while the cystatin
family possesses is three common binding sites. Since
lactoferrin possesses only one binding domain, it
may be considered a VEGprotein-type inhibitor, although
it belongs to the cystatin super family.
Furthermore, we found some novel types of new
inhibitors from the cystatin family in human tearswith
certain autoimmune diseases.
A new method for detecting cysteine protease inhibitors
in biological materials, named “reverse zymography”,
was used in this study.
MATERIALS AND METHODS
Inhibition analysis of the transferrin family against
cysteine proteases
Recombinant rat liver cathepsins B, L, and C were
used for inhibitory assay. Recombinant cathepsins
K and S were expressed and purified according to the
methods of Katunuma (10), Kopitar (11), and Bossard
(12). The cysteine proteases were assayed using Z-
Phe-Arg-MCA as a substrate for cathepsins L, B, S,
K and papain, following the method of Barrett (13).
Synthesized peptide of near C-terminus 17 mer peptide
of lactoferrin
The near C-terminus 17 mer peptide (Y679-K695)of
lactoferrin and 19mer (L142-H160) of human β-caseinwere
chemically synthesized by Asahi Technoglass Co.
(Chiba, Japan) with 95% purity. The synthesized peptide
sequences were YEKYLGPQYVAGITNLK (Y679-K695)
and LTDVENLHLPLPLLQSWMH (L142-H160).
Preparation of intramolecular peptides of β-casein
Bovine β-casein (250µg) in 100mM Tris-HCl buffer
pH 8.5 was digested by lysylendopeptidase at 35℃ for
16 hours. The digested sample was applied to HPLC,
TSK gelDDS-80Tsandelutedby a lineargradient using
solvents of 0.1% TFA and 0.1% TFA in 90% acetonitrile.
The main eluted peakswere used to assay the inhibitory
activities and to determine the amino acid sequences.
Analysis of the N-terminus amino acid sequence
The N-terminus amino acid sequences of proteins
and the isolated intramolecular peptides were deter-
mined with anHPG1005A protein sequencing system
(Hewlett-Packard, Palo Alto, CA). After SDS-PAGE,
the bandswere transferred to a polyvinylidene difluoride
membrane, and then subjected to amino acid sequence
analysis using Majima’s method (14).
Negative staining method of the SDS-PAGE gel
Negative staining of the gel was performed by the
method of Fernandez, C. et al. (15). Samples of milk
(10 -15 µl) weremixedwith the sameamountof sample
buffer (0.125M Tris-HCl 4% SDS, 20% glycerol, 0.02%
bromophenol blue pH 6.8). After the electrophoresis,
the gels were incubated in a 0.2M imidazole solution
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for 10 minutes. The incubation time could bemodified
depending on the acrylamide percentage. Then, the
gels were transferred to a bath containing 0.2-0.3M
zinc sulfate for1minute. For visualization, the protein
bands were cut andwashedwith 2% citric acid to remove
the staining solution. The gel pieces containing the
protein bands were eluted and the eluates were used
to check the inhibitory activity of the various authentic
cysteine proteases.
RESULTS AND DISCUSSION
[1] Reverse zymography for the detection of cysteine
protease inhibitors in natural materials
We developed a new detection technique for cysteine
protease inhibitors in crude natural materials, and
named it“reverse zymography”as shown in Fig.1.
The principal of this detection method of protease
inhibitors on SDS -PAGE is the reverse of that in usual
zymography. The inhibitor samples were applied to
special SDS gels co-coagulated with gelatin or without
gelatin as the control. To digest the embedded gelatin,
the gels were incubatedwithpapain solution.Theembed-
ded gelatin and the coexistent proteins in the sample
were digested. Gelatin preserved in the bands, in which
the inhibitors were located,was stainedwithCoomassie
brilliant blue. The SDS-PAGEwasperformed following
the Laemmli method (16). Milk or tears were diluted
with the same amount of a solution.After electrophoresis,
the gel was removed, washed and transferred to a tray
of 100ml of acetatebuffer containingpapainand incubated
at 37 ℃ for 10hours to digest the gelatin. The gel was
washed withdistilledwater and thenstainedwithCoomas-
sie brilliant blue. Thegelswere thenwashedwithdestain-
ing solution. Putative protease inhibitors were detected
as bluebandsonaclearbackground.Thereversezymogra-
phy was compared with and without gelatin plates.
[2] Basic demonstrations for detection of authentic
protease inhibitors using the reverse zymography
method
To demonstrate the corresponding inhibitors against
the various target proteases using our reverse zymogra-
phy, well-established authentic protease inhibitors and
the pure corresponding proteases were employed. For
example, the pairs for reverse zymography, cystatin
C for papain, lactoferrin for papain and soybean trypsin
inhibitor for trypsin, are demonstrated in Fig.2. After
electrophoresis of the gelatin gel to which cystatin
C or lactoferrin was applied, the gel was incubated
with papain to hydrolyze the background gelatin. The
washed gel was stainedwith Coomassie brilliant blue.
Only the bands in which cystatin C or lactoferrin was
located were stained at positions corresponding to
15 kDa or 78kDa, respectively, because the embedded
gelatin in the inhibitor bands remained, as shown in
Fig.2-B or Fig.2-C, respectively. Using the samemethod,
soybean trypsin inhibitor was detected in the 25 kDa
area using trypsinas thecorrespondingdigestive protease
to remove the embedded gelatin as Fig.2-A shows. The
without-gelatin gels were used as their controls. We
could selectively detected corresponding inhibitors
to various target proteases by choosing various target
proteases as digesting proteases of the embedded
gelatin in the gel. Without-gelatin gels were used as
the corresponding controls as shown in lanes 3, 5 or
7 in Fig.2. The contaminated proteins in the natural
materials were also digested out to produce a clean
background. The remaining gelatin in the inhibitor
band was stained blue on a white background.
Fig.1. Schematic illustration of “Reverse Zymography” method
for cysteine protease inhibitors.
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[3] Disease-specific expression of new inhibitors in
human tears
(1) Inhibitory proteins of cysteine proteases in normal
human tears
More than10kinds of major protein components
in normal human tears were detected usingCoomassie
brilliant blue staining of SDS-PAGE and aswell as by
the negative staining of the SDS-PAGE, as shown in
Fig.3. To detect the bands of cysteine protease inhibitors
in human tears, our reverse zymography of gelatinolysis
inhibition to papain was employed. As shown in Fig.3,
at least two different kinds of strong staining bands
of 78kDa and 15kDa and very weak staining bands
of 65kDa and 20kDa in normal tears were detected
by the reverse zymography, although the comparative
strengths showed some individual differences. And
very weak 65kDa band was detected in a rare case of
normal tears.
(2) Identification and properties of normal tears inhibitors
The structures of the three bands, showing strong
inhibitory activity, were identified using amino acid
sequence analysis of their N-terminus area and/or
the sequences of their intramolecular peptides. The
20 kDa inhibitor was identical to VEG protein based
on the amino acid sequence analysis (8), and the band
was cross-reacted with polyclonal antibody against
anti-19 mer of N-terminus peptide, L21-A39(chemically
synthesized), of the VEG proteinmolecule. The VEG
protein was reported by Hof et al. to be a member of
the cystatin super-family (8). The 15kDa inhibitor was
estimated to be cystatin S, which is known to be a
member of the cystatin family in saliva based on the
molecular weight, the inhibitory profiles and the cross-
reactivity with anti-cystatinSantibody (17).The78 kDa
Fig.2. Specific detection of authentic protease inhibitors by reverse
zymography.
Lanes1 and 8 are molecular markers. [A] Soybean trypsin inhibitor
was applied in lanes 2 and 3, and embeddedgelatinwas digested out
by trypsin;Lane2 is with-gelatin gel and lane3 is without-gelatin
gel as the control. The remaining gelatin band in the soybean trypsin
inhibitor band of 25 kDa is stained by Coomassie brilliant blue in
lane 2. [B] Cystatin C was applied in lanes 4 and5, and the embedded
gelatin was digested out by papain;lane4 is with-gelatin gel and
lane 5 is without-gelatin gel as the control. The remaining gelatin
band in the cystatinCbandof 15 kDa is stained in lane 4. [C] Lactoferrin
was applied in lanes 6 and 7, and the embeddedgelatinwas digested
out by papain;lane 6 is with-gelatin gel plate and lane 7 is without-
gelatin gel plate as the control. The remaining gelatin in the lactoferrin
band of 78kDa is stained in lane 6. The without-gelatin control gels
in lanes 3, 5 and 7 are not stained.
Fig.3. Reverse zymography of normal human tears.
The same amount of normal human tears were applied in lanes
1, 2 and 3. Lane1 ; normal tearswas stainedbyCoomassie brilliant blue.
Lane 2 ; normal tears was stained by negative Z staining method.
Lane 3 ; normal tears was stained by reverse zymographymethod.
Three main inhibitor bands were detected in78kDa of lactoferrin,
20 kDa of Von Ebner’s Gland perotein and 15 kDa of cystatin S.
Lane 4 ; recombinant lactoferrin was stained in 78 kDa band.
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band inhibitor was determined as being a lactoferrin
from theN-terminus sequence (20). The naturesof the
78kDa, 65kDa, 20kDa and 15kDa bands were finally
determined as lactoferrin, Ig heavy chain-V-Ⅲ region,
VEG protein and cystatin S, respectively, based on their
amino acid sequence analysis. As shown in Fig.4, the
near C-terminus peptide Y679-K695, of the lactoferrinmole-
cule showed a strong homologous sequence with a
common active site (binding site) of the cystatin family.
In practice, this domain peptide synthesized chemically
showed considerable inhibition to various cysteine
proteases. Since the inhibition kinetics of lactoferrin
to papain is of a non-competitive type, it is suggested
that the lactoferrin does not compete with the synthetic
substrate of papain. Authentic lactoferrin and β-casein
were not degraded after incubation with papain using
SDS-PAGE. Lactoferrin has been known to possess
bacteriostatic action(18, 19), but the mechanism has
not been determined. We clarified that the inhibition
of cysteine proteases by lactoferrin must play amajor
role in exhibiting bactericidal and anti-septic functions,
due to the strong cysteineprotease inhibitionof bacteria
and viruses (7, 8).
(3) Characteristic changes in the inhibitor profiles in
pathological tears and detection of new disease-specific
inhibitors in tears with specific autoimmune diseases
The cysteine protease inhibitor profiles in tears of
certain diseases showed characteristic changes from
those of normal tears, and furthermore, novel disease-
specific inhibitors were found in some autoimmune
diseases (21). Characteristic reddish bands of 31kDa
stained strongly with Coomassie brilliant blue were
detected specifically in all eight cases ofBehcet’s disease
which is an autoimmune disease, as Fig.5 (b) shows,
and the lactoferrin contents in these caseswere relatively
high. The N-terminus sequence of the 31kDa reddish
band specifically detected in thecasesofBehcet’s disease
was 100% identical with that of human lacrimal acidic
proline-rich protein. Furthermore, the eluates of the
31 kDa band area of SDS-PAGE (not stained) in the
tears withBehcet’sdisease showedabout 50% inhibition
of papain at the protein concentration of 10-6 M. The
cysteine protease inhibition of this kind of acidic proline-
rich protein family has not been reported before. In
the tears from four cases withHarada’s disease, which
is a typical autoimmune disease, the 65kDa inhibitors
were strong and the lactoferrin content was relatively
weak compared with those of normal tears as shown
in Fig.5 (c). The 65 kDa band inhibitor expressed
strongly in the cases of Harada’s disease tears was
determined as being a human Ig heavy chain V-Ⅲ
region based on the N-terminus sequence analysis.
The N-terminus 10 mer sequence of the 65kDa band
inhibitor was 100% identical with the human Ig heavy
chain V-Ⅲ region sequence. These inhibitorsmay have
a relationship with the pathogenesis of these auto-
immune diseases. The IgheavychainofvariableⅢregion
was secreted extensively inHarada’s autoimmunedisease
tears. Quantitative changes in the typical patterns of
these inhibitors in specific eye diseases are compared
by a scanning densitometry method in Fig.5.
Characteristic changes in these inhibitor contents
and the expression of disease-specific inhibitors were
found in Behcet’s disease andHarada’sdisease. These
unique changes in cysteine protease inhibitors in tears
with specific autoimmune diseases may not only lead
to the elucidation of their pathogenesis, but also be
useful for differential diagnosis. The autoantigen of
Fig.4. Homology of lactoferrin sequence near the C-terminus showing high frequency amino acids of common active site of
the cystatin family.
Peptide sequence, Y679-K695, of lactoferrin showed 89% homology and 61% identity with that of active site of the cystatin family
and transferrin sequence of the corresponding part had 78% homology and 28% identity with that of the cystatin family.
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Behcet’s diseases is still unknown. It couldbe speculated
that the proline-rich proteins are possible candidate
of specific autoantigens that induce Behcet’s disease,
because these proteins belong to the collagen family.
[4] Lactoferrin and β -casein in mammalian milk
as cysteine protease inhibitors
(1) Detection of lactoferrin and β-casein as cysteine protease
inhibitors in human and cow milk
Human and cow milk were found to contain two
cysteine protease inhibitors, namely lactoferrin and
β-casein, using our reverse zymography for papain
inhibition. The main inhibition bands in cow and human
milk were found with apparent molecular weights
of 78 kDa and35kDa,whichshowedthesamemigration
with recombinant lactoferrin and β-caseinon their SDS-
PAGE, respectively, as shown in Fig.6. Lane1shows
all the proteins inmilk using normal SDS-PAGE staining
with Coomassie brilliant blue. Lane2 shows the papain
inhibition bands due to 78kDa of lactoferrin and 35kDa
of β-casein in milk using reverse zymography, and lane
3 shows the control without the gelatin plate. Lanes
4 and lane 5 show reverse zymography of recombinant
lactoferrin and lanes 5shows the control without the
gelatin plate. Reverse zymography of recombinant
human β-casein is shown in lanes 6 and 7, and lane 8 is
the control without the gelatin plate. Lactoferrin and β-
casein are the major inhibitors of cysteine proteases
in mammalian milk.
The 78 kDa and 35 kDa staining bands of human
milk were identified as lactoferrin and β-casein based on
analysis of their N-terminus sequences. TheN-terminus
10 mer sequence of the 78kDa band was completely
identical to that of lactoferrin and theN-terminus15mer
sequence of the 35kDa bandwas completely identical
Fig.5. Disease-specific inhibitor patterns in typical cases of specific
eye diseases were demonstrated quantitatively using thegel scanning
method of reverse zymography.
Panel (a): normal tears. Panel (b): tears with Behcet’s disease.
Panel (c) : tears with Harada’s disease.
No.1 band of 78kDa is lactoferrin. No.2 band of 65kDa is Ig heavy
chain V-Ⅲ region. No.4 reddish band of 31kDa is lacrimal acidic
proline-rich protein of Behcet’s disease-specific inhibitor. No.5 band
of 20 kDa is VEG protein. No.6 band of 15 kDa is cystatin S.
Fig.6. Detection of papain inhibitors in cow milk using reverse
zymography of gelatinolysis inhibition.
Lane1 shows all the proteins in cow milk stained by Coomassie
brilliant blue. Lanes 2 and 3 show reverse zymography of cowmilk
and lane 3 shows that without the gelatin plate as the control. Lanes
4 and 5 show reverse zymography of authentic lactoferrin and lane
5shows that without the gelatin plate as the control. Lanes 6 and 7
show reverse zymography of authentic β-casein and lane 8 shows
that without the gelatin plate as the control.
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with that of human β-casein. Furthermore, the eluates
from the 78kDa band and the 35kDa band of the negative
staining SDS -PAGE gel showed the inhibition of various
cysteine proteases.
(2) Inhibition characteristics of human β-casein to cysteine
proteases
β-Casein inhibited papain completely at 10-6 M. The
inhibitory specificities of β-casein to various cysteine
proteases were tested. β-Casein inhibitedpapain strongly
and inhibitedcathepsinLweakly at 10-5 M,but cathepsin
B was not inhibited at10-5 M. However, we could not
find homologous domain in the β-caseinmolecule with
a common active site sequence of the cystatin family.
Therefore, the inhibition mechanism must be different
from that of cystatin. The inhibitionmode of human β-
casein to papain showed sigmoidal allosteric inhibition
kinetics. The inhibitionkineticsofhumanβ-caseinshowed
a second order sigmoidal curve to the substrate and
the reciprocal plot between1/v and1/[S]2gave a straight-
line. A Hill constant was calculated as n=2.4using the
Hill equation of log (v/Vm-v)= n log [S]-log Km (Vmax=
9,000 U and Km=0.0079). The hydrolyzed products of
bovine β-casein by lysylendopeptidase showed about
the same inhibition as that of intact β-casein. Theproduct
peptides by the digestionwere separated using reverse-
phase HPLC, the papain inhibitionsof thesemainpeptides
were assayed and the inhibitory peptide sequences were
determined as LTDVENLHLPLPLLQSWMH(L142-H160)
in bovine β-casein and LTDLENLHLPLPPLPLLQPLMH
(L133-Q151) in human β-casein. Both peptide sequences
showed 79% identity and 84% homology to each other.
The synthesized peptide of L133-Q151in human β-casein
showed significant inhibition to papain, and the peptide
showed 68% inhibition at 10-5M and 100% inhibition
at 10-4M, but the other parts of the separated peptides
showed no inhibition. β-Casein is not only a nutritional
protein source, but also plays a role as a cysteine pro-
tease inhibitor. The biological roles of cysteine protease
inhibitors of lactoferrin and β-casein inmammalianmilk
are important from medical aspects. One of the im-
portant functions of lactoferrin and?-casein in milk
may be to exert inhibitory effects to cysteine proteases
of bacteria and viruses to play a role in anti-infectious
and anti-septic functions (7, 8).
These contents were published in the following
original papers.
1)A. Ohashi, E. Murata, K. Yamamoto, E. Majima,
E. Sano, Q. T. Le and N. Katunuma: New functions
of lactoferrin and β-casein in mammalian milk as
cysteine protease inhibitors., BBRC 306, 98-103 (2003).
2)Q. T. Le, E. Sano, A. Ohashi, E. Murata, H. Shiota,
M. Ishimaru, K. Yamamoto, E. Majima, S. Isemura,
and N. Katunuma : Disease-specific cysteine protease
inhibitors in tears with autoimmune-diseases. (2003)
in preparation of Archives of Ophthalmology. 3)N.Katunuma,
A. Ohashi, E. Sano, E.Murata, H. Shiota,K. Yamamoto,
E. Majima andQ. T. Le : New cysteine protease inhibi-
tors in physiological secretory fluids and their medical
significances., Advances in Enzyme Regulation43, 393-410
(2003).
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